What Is Echinacea? Benefits, Uses and Forms
A complete guide to echinacea: the purple coneflower, its species and active compounds, honest evidence for colds and immunity, forms, dosage and safety.
Read MoreSkip to the content
A complete guide to echinacea: the purple coneflower, its species and active compounds, honest evidence for colds and immunity, forms, dosage and safety.
Read More
Organic MCP uses USDA-certified citrus peel and solvent-free processing. 8 brands certified in 2026, 30-50% price premium, and how to verify quality.
Read More
MCP during chemotherapy: 4 Phase 2 trials at 14.4 g/day, drug interactions, timing 2-4 hours from oral chemo, and how to talk to your oncology team safely.
Read More
Galectin-3 inhibitors block a protein elevated in 75% of solid tumors. Natural sources, MCP at 14.4 g/day, and pharmaceutical candidates explained.
Read More
Oregano oil vs antibiotics: carvacrol inhibits 12+ bacterial species in vitro at MIC values of 0.03–0.5 mg/mL. No human RCT has confirmed equivalent efficacy to prescription antibiotics for any bacterial...
Read More
Oregano oil for parasites works through carvacrol, a phenolic compound that disrupts protozoan cell membranes at concentrations as low as 0.02% in vitro. In-vitro studies show activity against Giardia lamblia,...
Read More
Modified citrus pectin (MCP) and cancer research connect through 1 key mechanism: MCP blocks galectin-3, a protein tumors overexpress to metastasize. The strongest human evidence comes from prostate cancer trials...
Read More
Buying oregano oil capsules comes down to 5 quality markers: carvacrol percentage, third-party testing, organic sourcing, a short ingredient list, and price per serving. The strongest formulas standardize carvacrol to...
Read More
Oregano oil capsules vs softgels differ mainly in absorption speed and shelf stability, with liquid-filled softgels absorbing up to 40% faster than dried powder capsules. Both formats deliver a standardized...
Read More
Modified citrus pectin kidney research focuses on galectin-3 inhibition in renal fibrosis, with animal studies showing 50% reduction in fibrotic markers at therapeutic doses. Human trial evidence in chronic kidney...
Read More
Modified citrus pectin breast cancer research focuses on galectin-3 inhibition, with preclinical work showing 80% reduction in MDA-MB-231 cell adhesion at therapeutic concentrations. Human trial data is preliminary — only...
Read More
Modified citrus pectin inflammation research targets galectin-3, a master regulator that amplifies TNF-α and IL-6 in chronic disease states. Animal models show MCP cuts inflammatory cytokines 30–60% at therapeutic doses...
Read More